BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27821638)

  • 1. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction.
    Palevsky PM
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2078. PubMed ID: 27821638
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.
    McCullough PA; Ball T; Cox KM; Assar MD
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2079-2084. PubMed ID: 27797888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
    Keskar V; Sood MM
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2085-2092. PubMed ID: 27797891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Zaman JAB; Bhandari AK
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):499-508. PubMed ID: 31284744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxysmal Atrial Fibrillation in a Patient on Hemodialysis.
    Lok CE
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1176-1180. PubMed ID: 28600457
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral Anticoagulation in End-Stage Renal Disease: Is It Time to Absolve Warfarin?
    Genovesi S
    Am J Nephrol; 2016; 44(4):255-257. PubMed ID: 27598337
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NOAK in atrial fibrillation and renal failure].
    St
    MMW Fortschr Med; 2016 Mar; 158(4):16. PubMed ID: 27119860
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulants, renal failure and atrial fibrillation.
    Genovesi S; Santoro A
    Expert Opin Drug Saf; 2013 Jan; 12(1):1-3. PubMed ID: 23163428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients?
    Lane DA; Lip GY
    Nat Rev Cardiol; 2013 May; 10(5):241-2. PubMed ID: 23546443
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.
    Di Biase L
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892528
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
    Shen JI; Turakhia MP; Winkelmayer WC
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):600-6. PubMed ID: 23079746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsolved issues in oral anticoagulation treatment in atrial fibrillation.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):60-61. PubMed ID: 30874812
    [No Abstract]   [Full Text] [Related]  

  • 16. New Oral Anticoagulants: Need and Challenges in a Developing Country.
    Khan M; Wasay M
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):551-2. PubMed ID: 27504541
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the risk of stroke in permanent and paroxysmal atrial fibrillation really the same? Therein lies the dilemma.
    Genovesi-Ebert A; Sorini-Dini C; Di Fusco SA; Imperoli G; Colivicchi F
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):540-546. PubMed ID: 32618760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion].
    Merella P; Casu G; Mazzone P; Lorenzoni G; D'Angelo G; Genovesi S
    G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
    Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.
    Molnar AO; Sood MM
    Semin Dial; 2018 Jan; 31(1):37-47. PubMed ID: 28699181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.